Advertisement

Specific Anatomic Considerations for Tricuspid Interventions

  • Ryan P. LauEmail author
  • Gregory A. Fishbein
  • Michael C. Fishbein
Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)
  • 130 Downloads
Part of the following topical collections:
  1. Topical Collection on Structural Heart Disease

Abstract

Purpose of Review

This review discusses the normal anatomy and pathology of the tricuspid valve (TV) and right side of the heart. Emphasis is on those anatomic and pathologic features relevant to interventions intended to restore normal function to the TV in disease states.

Recent Findings

TV pathology is less common than aortic and mitral valve pathology, and treatment and outcomes for interventions face considerable hurdles. New innovations and early data showing safety and efficacy in transcatheter interventions have transformed TV interventions into the next frontier in cardiac valve disease treatment. Certain features of the TV and right heart have presented themselves as potential targets, as well as impediments, for TV intervention.

Summary

The causes of TV pathology and the anatomy of the TV and right heart bring unique challenges to intervention. Approaches to intervention will continue to progress and change the way we view and treat TV pathology.

Keywords

Tricuspid regurgitation Tricuspid interventions Tricuspid valve anatomy Tricuspid valve surgery Tricuspid stenosis Transcatheter intervention 

Notes

Compliance with Ethical Standards

Conflict of Interest

Ryan P. Lau, Gregory A. Fishbein, and Michael C. Fishbein declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    •• M. Abdelghani, J. Schofer, and O. Soliman, “Transcatheter interventions for tricuspid regurgitation: rationale, overview of current technologies, and future perspectives,” in Practical Manual of Tricuspid Valve Disease, O. Soliman and F. J. Ten Cate, Eds. Springer, 2018, pp. 353–377. This article provides a comprehensive review of the current state of developing percutaneous interventions for tricuspid valve pathology. Google Scholar
  2. 2.
    Hollman A. The anatomical appearance in rheumatic tricuspid valve disease. Br Heart J. 1957;19(2):211–6.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Huttin O, Voilliot D, Mandry D, Venner C, Juillière Y, Selton-Suty C. All you need to know about the tricuspid valve: tricuspid valve imaging and tricuspid regurgitation analysis. Arch Cardiovasc Dis. 2016;109(1):67–80.PubMedCrossRefGoogle Scholar
  4. 4.
    Stuge O, Liddicoat J. Emerging opportunities for cardiac surgeons within structural heart disease. J Thorac Cardiovasc Surg. 2006;132(6):1258–61.PubMedCrossRefGoogle Scholar
  5. 5.
    P. Vaideeswar and J. Butany, “Valvular heart disease,” in Cardiovascular pathology, 4th ed., J. Butany and L. Buja, Eds. Elsevier Academic Press, 2016, pp. 485–528.Google Scholar
  6. 6.
    Matsuyama K, Matsumoto M, Sugita T, Nishizawa J, Tokuda Y, Matsuo T. Predictors of residual tricuspid regurgitation after mitral valve surgery. Ann Thorac Surg. 2003;75(6):1826–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J. 2002;144(3):524–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Sagie A, Schwammenthal E, Newell JB, Harrell L, Joziatis TB, Weyman AE, et al. Significant tricuspid regurgitation is a marker for adverse outcome in patients undergoing percutaneous balloon mitral valvuloplasty. J Am Coll Cardiol. 1994;24(3):696–702.PubMedCrossRefGoogle Scholar
  9. 9.
    Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Lauten A, Ferrari M, Hekmat K, Pfeifer R, Dannberg G, Ragoschke-Schumm A, et al. Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J. 2011;32(10):1207–13.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Tanous D, Nadeem SN, Mason X, Colman JM, Benson LN, Horlick EM. Creation of a functional tricuspid valve: novel use of percutaneously implanted valve in right atrial to right ventricular conduit in a patient with tricuspid atresia. Int J Cardiol. 2010;144(1):e8–10.PubMedCrossRefGoogle Scholar
  12. 12.
    Webb JG, Wood DA, Ye J, Gurvitch R, Masson JB, Rodés-Cabau J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121(16):1848–57.PubMedCrossRefGoogle Scholar
  13. 13.
    Maisano F, Taramasso M. Transcatheter tricuspid valve therapies: exploring the dark side of the moon. Eur J Heart Fail. 2018;20:1063–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Taramasso M, Zuber M, Kuwata S, Nietlispach F, Maisano F. Clipping of the tricuspid valve: proposal of a Rosetta stone nomenclature for procedural 3D transoesophageal guidance. EuroIntervention. 2017;12:e1825–7.PubMedCrossRefGoogle Scholar
  15. 15.
    T. W. Sadler, “Cardiovascular system,” in Langman’s medical embryology, 14th ed., Wolters Kluwer, 2019, pp. 179–222.Google Scholar
  16. 16.
    Habib A, Lachman N, Christensen KN, Asirvatham SJ. The anatomy of the coronary sinus venous system for the cardiac electrophysiologist. Europace. 2009;11(Suppl 5):v15–21.PubMedCrossRefGoogle Scholar
  17. 17.
    Schneider B, Hofmann T, Justen MH, Meinertz T, “Chiari’s network: normal anatomic variant or risk factor for arterial embolic events?,” J Am Coll Cardiol, 1995.Google Scholar
  18. 18.
    R. Anderson and A. Becker, Cardiac anatomy: an integrated text and color atlas. Gower Medical, 1980.Google Scholar
  19. 19.
    Rodés-Cabau J, Taramasso M, O’Gara PT. Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet. 2016;388:2431–42.PubMedCrossRefGoogle Scholar
  20. 20.
    J. Maleszewski, C. Lai, and J. Veinot, “Anatomic considerations and examination of cardiovascular specimens (excluding devices),” in Cardiovascular pathology, 4th ed., M. Buja and J. Butany, Eds. Elsevier Academic Press, 2016, pp. 1–22.Google Scholar
  21. 21.
    Dwivedi G, Mahadevan G, Jimenez D, Frenneaux M, Steeds RP. Reference values for mitral and tricuspid annular dimensions using two-dimensional echocardiography. Echo Res Pract. 2014;1:43–50.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    • E. Downs and G. Ailawadi, “Anatomic considerations for tricuspid valve interventions,” in Catheter based calve and aortic surgery, G. Ailawadi and I. L. Kron, Eds. Springer, 2018, pp. 295–304. This very current publication explores available and experimental interventions, while examining how certain anatomic features may impact their effectiveness. Google Scholar
  23. 23.
    Wafae N, Hayashi H, Gerola LR, Vieira MC. Anatomical study of the human tricuspid valve. Surg Radiol Anat. 1990;12:37–41.PubMedCrossRefGoogle Scholar
  24. 24.
    Victor S, Nayak VM. The tricuspid valve is bicuspid. J Heart Valve Dis. Jan. 1994;3(1):27–36.PubMedGoogle Scholar
  25. 25.
    Allwork SP, Anderson RH. Developmental anatomy of the membranous part of the ventricular septum in the human heart. Br Heart J. 1979;41(3):275–80.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    B. Wilcox, A. Cook, and R. Anderson, Surgical anatomy of the heart, 3rd ed. Cambridge University Press, 2004.Google Scholar
  27. 27.
    Wenink AC. The medial papillary complex. Br Heart J. 1977;39(9):1012–8.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Saha A, Roy S. Papillary muscles of right ventricle-morphological variations and its clinical relevance. Cardiovasc Pathol. 2018;34:22–7.PubMedCrossRefGoogle Scholar
  29. 29.
    F. Schoen and R. Mitchell, “The heart,” in Robbins and Cotran pathologic basis of disease, 9th ed., A. Abbas, V. Kumar, and J. Aster, Eds. Elsevier/Saunders, 2015, pp. 523–578.Google Scholar
  30. 30.
    Hauck AJ, Freeman DP, Ackermann DM, Danielson GK, Edwards WD. Surgical pathology of the tricuspid valve: a study of 363 cases spanning 25 years. Mayo Clin Proc. 1988;63(9):851–63.PubMedCrossRefGoogle Scholar
  31. 31.
    Cohen ML, Spray T, Gutierrez F, Barzilai B, Bauwens D. Congenital tricuspid valve stenosis with atrial septal defect and left anterior fascicular block. Clin Cardiol. 1990;13(7):497–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Essandoh M, Zuleta-Alarcon A, Weiss R, Sirak J, Dimitrova G, Wirtz C, et al. Transesophageal echocardiographic diagnosis of severe functional tricuspid stenosis during infected implantable cardioverter-defibrillator lead extraction. J Cardiothorac Vasc Anesth. 2015;29(2):412–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Saito T, Horimi H, Hasegawa T, Kamoshida T. Isolated tricuspid valve stenosis caused by infective endocarditis in an adult: report of a case. Surg Today. 1993;23(12):1081–4.PubMedCrossRefGoogle Scholar
  34. 34.
    Reddy G, Ahmed M, Alli O. Percutaneous valvuloplasty for severe bioprosthetic tricuspid valve stenosis in the setting of infective endocarditis. Catheter Cardiovasc Interv. 2015;85(5):925–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Heaven DJ, Henein MY, Sutton R. Pacemaker lead related tricuspid stenosis: a report of two cases. Heart. 2000;83(3):351–2.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;63(22):2438–88.PubMedCrossRefGoogle Scholar
  37. 37.
    Sattar SBA, Kanmanthareddy A, Balloon Valvuloplasty. 2018.Google Scholar
  38. 38.
    Dreyfus GD, Martin RP, Chan KMJ, Dulguerov F, Alexandrescu C. Functional tricuspid regurgitation: a need to revise our understanding. J Am Coll Cardiol. 2015;65(21):2331–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Rodés-Cabau J, Hahn RT, Latib A, Laule M, Lauten A, Maisano F, et al. Transcatheter therapies for treating tricuspid regurgitation. J Am Coll Cardiol. 2016;67(15):1829–45.PubMedCrossRefGoogle Scholar
  40. 40.
    Mutlak D, Lessick J, Reisner SA, Aronson D, Dabbah S, Agmon Y. Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation. J Am Soc Echocardiogr. 2007;20(4):405–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Lozano HF, Sharma CN. Reversible pulmonary hypertension, tricuspid regurgitation and right-sided heart failure associated with hyperthyroidism: case report and review of the literature. Cardiol Rev. 2004;12(6):299–305.PubMedCrossRefGoogle Scholar
  42. 42.
    Delling FN, Hassan ZK, Piatkowski G, Tsao CW, Rajabali A, Markson LJ, et al. Tricuspid regurgitation and mortality in patients with transvenous permanent pacemaker leads. Am J Cardiol. 2016;117(6):988–92.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Meduri C, Rajagopal J, Vannan M, Latib A. Transcatheter tricuspid valve therapies: a look at the current state of this final valve frontier. Card Interv Today. 2017;11(4).Google Scholar
  44. 44.
    Nguyen V, Cantarovich M, Cecere R, Giannetti N. Tricuspid regurgitation after cardiac transplantation: how many biopsies are too many? J Heart Lung Transplant. 2005;24(7 Suppl):S227–31.PubMedCrossRefGoogle Scholar
  45. 45.
    Bhimani AA, Hoit BD. Extensive nonbacterial thrombotic endocarditis isolated to the tricuspid valve in primary antiphospholipid syndrome. J Am Soc Echocardiogr. 2010;23(1):107.e5–6.CrossRefGoogle Scholar
  46. 46.
    Hung J. The pathogenesis of functional tricuspid regurgitation. Semin Thorac Cardiovasc Surg. 2010;22(1):76–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Zack CJ, Fender EA, Chandrashekar P, Reddy YNV, Bennett CE, Stulak JM, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. 2017;70(24):2953–60.PubMedCrossRefGoogle Scholar
  48. 48.
    Alqahtani F, Berzingi CO, Aljohani S, Hijazi M, Al-Hallak A, Alkhouli M. Contemporary trends in the use and outcomes of surgical treatment of tricuspid regurgitation. J Am Heart Assoc. 2017;6(12).Google Scholar
  49. 49.
    •• Asmarats L, Puri R, Latib A, Navia JL, Rodés-Cabau J. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol. 2018;71(25):2935–56 This study looks at the many up to date interventions available for tricuspid valve intervention and their associated clinical outcomes. It also examines pathophysiology of TR and the preprocedural screening of patients.PubMedCrossRefGoogle Scholar
  50. 50.
    Puri R, Rodés-Cabau J. The FORMA repair system. Interv Cardiol Clin. 2018;7(1):47–55.PubMedGoogle Scholar
  51. 51.
    Rogers T, Ratnayaka K, Sonmez M, Franson DN, Schenke WH, Mazal JR, et al. Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv. 2015;8(3):483–91.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Navia JL, Kapadia S, Elgharably H, Harb SC, Krishnaswamy A, Unai S, et al. First-in-human implantations of the NaviGate bioprosthesis in a severely dilated tricuspid annulus and in a failed tricuspid annuloplasty ring. Circ Cardiovasc Interv. 2017;10(12).Google Scholar
  53. 53.
    Hai T, Amador Y, Mahmood F, Jeganathan J, Khamooshian A, Knio ZO, et al. Changes in tricuspid annular geometry in patients with functional tricuspid regurgitation. J Cardiothorac Vasc Anesth. 2017;31(6):2106–14.PubMedCrossRefGoogle Scholar
  54. 54.
    Kim H-K, Kim YJ, Park JS, Kim KH, Kim KB, Ahn H, et al. Determinants of the severity of functional tricuspid regurgitation. Am J Cardiol. 2006;98(2):236–42.PubMedCrossRefGoogle Scholar
  55. 55.
    Fukuda S, Song JM, Gillinov AM, McCarthy PM, Daimon M, Kongsaerepong V, et al. Tricuspid valve tethering predicts residual tricuspid regurgitation after tricuspid annuloplasty. Circulation. 2005;111(8):975–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Buzzatti N, De Bonis M, Moat N. Anatomy of the tricuspid valve, pathophysiology of functional tricuspid regurgitation, and implications for percutaneous therapies. Interv Cardiol Clin. 2018;7(1):1–11.PubMedGoogle Scholar
  57. 57.
    Starck CT, Kempfert J, Falk V. Tricuspid valve interventions: surgical techniques and outcomes. EuroIntervention. 2015;11 Suppl W:W128–32.PubMedCrossRefGoogle Scholar
  58. 58.
    McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004;127(3):674–85.PubMedCrossRefGoogle Scholar
  59. 59.
    Nazmul MN, Cha Y-M, Lin G, Asirvatham SJ, Powell BD. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation. Europace. 2013;15(3):409–13.PubMedCrossRefGoogle Scholar
  60. 60.
    Loukas M, Sullivan A, Tubbs RS, Weinhaus AJ, Derderian T, Hanna M. Chiari’s network: review of the literature. Surg Radiol Anat. 2010;32(10):895–901.PubMedCrossRefGoogle Scholar
  61. 61.
    Pozzoli A, Taramasso M, Zuber M, Maisano F. Transcatheter tricuspid valve repair with the MitraClip system using intracardiac echocardiography: proof of concept. EuroIntervention. 2017;13(12):e1452–3.PubMedCrossRefGoogle Scholar
  62. 62.
    Vismara R, Gelpi G, Prabhu S, Romitelli P, Troxler LG, Mangini A, et al. Transcatheter edge-to-edge treatment of functional tricuspid regurgitation in an ex vivo pulsatile heart model. J Am Coll Cardiol. 2016;68(10):1024–33.PubMedCrossRefGoogle Scholar
  63. 63.
    Taramasso M, Pozzoli A, Basso C, Thiene G, Denti P, Kuwata S, et al. Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies. EuroIntervention. 2018;13(16):1889–98.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Ryan P. Lau
    • 1
    Email author
  • Gregory A. Fishbein
    • 1
  • Michael C. Fishbein
    • 1
  1. 1.David Geffen School of Medicine at University of California, Los AngelesLos AngelesUSA

Personalised recommendations